Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2009. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) and their connected persons, rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding share transactions and does not contain financial performance data.
Material Changes
The material change disclosed is the partial vesting of a Performance Share Plan award made in 2006 to a connected person of Dr. M. Slaoui. This event resulted in the vesting of 1,200 Ordinary shares of GlaxoSmithKline plc. The balance of the Award lapsed.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance notification under Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Type: Partial vesting of a 2006 Performance Share Plan award.
- Individual Involved: Dr. M. Slaoui (PDMR) and a connected person.
- Share Impact: 1,200 Ordinary shares vested; the remainder of the award lapsed.
- Notification Date: The Company and the connected person were advised on February 19, 2009.
- Reporting Date: February 20, 2009.